On Tuesday 28th June 2016 OHE held a workshop on the topic of surrogate endpoints as predictors of overall survival in oncology. The workshop was commissioned by the Pharmaceutical Oncology Initiative (POI) as part of a wider research project being undertaken by OHE.
The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and Evidence. This post contains presentations given by the OHE team.
A new publication, based on research conducted by OHE, suggests that by 2025 the disability adjusted life year (DALY) burden of dementia will have increased by 42% from the Global Disease Burden (GDB) 2010 estimate.
It is estimated that one in three people born in 2015 in the UK may develop dementia, and clinical development success rates for dementia drugs are consistently lower than those for other therapy areas.
This respected compilation contains data on demographics, expenditures, hospitals and workforce, and health services.
For nearly 40 years the OHE has been a specialist provider of data analytics to the health care and pharmaceutical sectors. The latest edition of the OHE Guide to UK Health and Health Care Statistics is now available online, providing both reliable statistics and a basic guide to their use.